The 59 references in paper O. Kuzmin B., N. Buchneva V., M. Pugaeva O., О. Кузьмин Б., Н. Бучнева В., М. Пугаева О. (2009) “ПОЧЕЧНЫЕ ГЕМОДИНАМИЧЕСКИЕ МЕХАНИЗМЫ ФОРМИРОВАНИЯ ГИПЕРТОНИЧЕСКОЙ НЕФРОПАТИИ // RENAL HEMODYNAMIC MECHANISMS DEVELOPMENT OF THE HYPERTENSIVE NEPHROPATHY” / spz:neicon:nefr:y:2009:i:4:p:28-36

1
Бикбов БТ, Томилина НА. Состояние заместительной терапии больных с хронической почечной недостаточнос­ тью в Российской Федерации в 1998-2005 гг. (Отчет по дан­ ным регистра Российского диализного общества). Нефрология и диализ 2007; 9 (1): 6-85
(check this in PDF content)
2
Bidani AK, Griffin KA. Long-term renal consequences of hypertension for normal and diseased kidney. Curr Opin Nephrol Hypertens 2002; 11 (1): 73-80
(check this in PDF content)
3
Kriz W, Eberhard E, Nobiling R et al. A role podocytes to counteract capillary wall distension. Kidney Int 1994; 45 (2): 369-376
(check this in PDF content)
4
Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul 2006; 290 (5): R1153-R1167
(check this in PDF content)
5
Just A. Mechanisms of renal blood flow autoregulation: dynamics and contributions. Am J Physiol Regul 2007; 292 (1): R1-R17
(check this in PDF content)
6
Brannstrom K, Morsing P, Arendshort WJ. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by Ang II and AT, receptor. Am J Physiol Renal 1996; 270 (5): F749-F755
(check this in PDF content)
7
Karlsen FM, Leyssac PP, Holstein-Rathlon NH. Tubuloglomerular feedback in Dahl rats. Am J Physiol Regul 1998; 274 (6): R1561-R1569
(check this in PDF content)
8
Takabatake T, Ushioqi Y, Ohta K. Hattory N. Attenuation of enhanced tubuloglomerular feedback activity in SHR by renal denervation. Am J Physiol Renal 1990; 258 (4, Pt 2): F980-F985
(check this in PDF content)
9
Churg J, Sobin CH. Benign nephrosclerosis. In: Churg J ed. Renal disease - classification and atlas of glomerular diseases. Igaku-Shoin, Tokio, 1982; 211-224
(check this in PDF content)
10
Raij L. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease. Am J Hypertens 2005; 18 [suppl 4s]: 95s-99s
(check this in PDF content)
11
Hills GS, Heudes D, Jacquot C et al. Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension. Kidney Int 2006; 69 (5): 823-831
(check this in PDF content)
12
Cortes P, Zhao X, Riser BL, Narins RG. Regulation of glomerular volume in normal and partially nephrectomized rats. Am J Physiol Renal 1996; 270 (2, Pt 2): F356-F370
(check this in PDF content)
13
Friedrich C, Endlich N, Kriz W, Endlich K. Podocytes are sensitive to fluid shear stress in vitro. Am J Physiol Renal 2006; 291 (4): F856-F865
(check this in PDF content)
14
Seikaky MG, Arant BS, Seney FD. Endogenous angiotensin concentrations in special intrarenal fluid compartments in the rat. J Clin Invest 1990; 86 (9): 1352-1357
(check this in PDF content)
15
Velez JCQ, Bland AM, Arthur J et al. Characterization of renin-angiotensin system enzyme activities in cultured podocytes. Am J Physiol Renal 2007; 293 (1): F398-F407
(check this in PDF content)
16
Wang L, Flannery PJ, Spurney RF. Characterization of angiotensin II-receptor subtypes in podocytes. J Lab Clin Med 2003; 142 (5): 313-321
(check this in PDF content)
17
Liebau MC, Lang D, Bohm J et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal 2006; 290 (3): F710-F719
(check this in PDF content)
18
Singh R, Singh AK, Alavi N, Leechy D. Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose. J Am Soc Nephrol 2003; 14 (4): 873­ 880
(check this in PDF content)
19
Ardaillou R, Chansel D, Chatziantoniou C, Dussaule JC. Mesangial AT1 receptors: expression, signaling and regulation. J Am Soc Nephrol 1999; 10 [suppl 11]: S40-S46
(check this in PDF content)
20
Goto M, Mukoyama M, Sugawara A et al. Expression and role of angiotensin II type 2 receptor in the kidney and mesangial cells of spontaneously hypertensive rats. Hypertens Res 2002; 25 (1): 125-133
(check this in PDF content)
21
Durvasula RV, Petermann AT, Hiromura K et al. Activation of local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004; 65 (1): 30-39
(check this in PDF content)
22
Becker BN, Yasuda T, Kondo S et al. Mechanical stretch/ relaxation stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Nephron Exp Nephrol 1998; 6 (1): 57-66
(check this in PDF content)
23
Gruden J, Thomas S, Burt D et al. Interaction of angiotensin II and mechanical stretch on vascular endothelial growth factor production by human mesangial cells. J Am Soc Nephrol 1999; 10 (3): 730-737
(check this in PDF content)
24
Hoffman S, Podlich D, Hahnel B et al. Angiotensin II type I receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 2004; 15 (6): 1475-1487
(check this in PDF content)
25
Obata J, Nakamura T, Takano H et al. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 2000; 18 (9): 1247-1255
(check this in PDF content)
26
Kang YS, Park YJ, Kim BK. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J Mol Endocrinol 2006; 36 (2): 377-378
(check this in PDF content)
27
Liy Y, Kang YS, Dai C et al. Epithelial-to-mesenchymal transition is a potential pathway to podocytes dysfunction and proteinuria. Am J Pathol 2008; 172 (2): 299-308
(check this in PDF content)
28
Ding G, Reddy K, Kapasi AA et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal 2002; 283 (1): F173-F180
(check this in PDF content)
29
Lai XX, Ding GH, Haang CX et al. Angiotensin II-induced podocytes apoptosis: a role of MAPK subtypes. Beijing Da Xue Bao 2004; 36 (2): 131-134
(check this in PDF content)
30
Shu S, Liu Y, Wang L, Meng QH. Transforming growth factor-beta 1 is associated with kidney damage in patients with essential hypertension: renoproctive effect of ACE inhibitor and/or angiotensin II receptor blocker. Nephrol Dial Transplant 2008; 23 (9): 2841-2846
(check this in PDF content)
31
Hirschberg R, Wang S, Mitu GM. Functional symbiosis between endothelium and epithelial cells in glomeruli. Cell Tissue Res 2008; 331 (2): 485-493
(check this in PDF content)
32
Eremina V, Baedle HJ, Quaggin SE. Role of the VEGF- signaling pathway in the glomerulus: evidence for crosstalk between components of glomerular filtration barrier. Nephron Physiol 2007; 106 (2): 32-37
(check this in PDF content)
33
Guan F, Villegas G, Teichman J et al. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP Am J Physiol Renal 2006; 291 (2): F422-F428
(check this in PDF content)
34
Eremina V, Cui S, Gerber H et al. Vascular endothelial growth factor signaling in the podocytes-endothelial compartment is required for mesangial cell migration and survival. J Am Nephrol 2006; 17 (3): 724-735
(check this in PDF content)
35
Chen S, Lee JS, Iglesias-de la Cruz MC et al. Angiotensin II stimulates alpha3 (IV) collagen production in mouse podocytes via TGF-beta and VEGF signaling: implication for diabetic nephropathy. Nephrol Dial Transplant 2005; 20 (7): 1320-1328
(check this in PDF content)
36
Thomas S, Vanuystel J, Gruden G et al. Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease. J Am Soc Nephrol 2000; 11 (7): 1236-1243
(check this in PDF content)
37
Amamiya T, Sasamura H, Mifune M et al. Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells. Kidney Int 1999; 56 (6): 2055-2063
(check this in PDF content)
38
Liu E, Marimoto M, Kitajima S et al. Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular function. J Am Soc Nephrol 2007; 18 (7): 2094-2104
(check this in PDF content)
39
Yamauchi T, Ogura T, Oishi T et al. The angiotensin 1- converting enzyme inhibitor cilazapril inhibits the platelet- derived growth factor B chain expression in glomeruli of spontaneously hypertensive rats. Ren Physiol Biochem 1995; 18 (5): 237-245
(check this in PDF content)
40
Higueruelo S, Romero R. Angiotensin II requires PDGF- BB to induce DNA synthesis in rat mesangial cells cultured in exogenous insulin free medium. Nephrol Dial Transplant 1997; 12 (4): 694-700
(check this in PDF content)
41
Floege J, Eitner F, Alpers CE. A new look at platelet- derived growth factor in renal disease. J Am Soc Nephrol 2008; 19 (1): 12-23
(check this in PDF content)
42
Kretzler M. Regulation of adhesive interaction between podocytes and glomerular basement membrane. Microsc Res Tech 2002; 57 (4): 247-253
(check this in PDF content)
43
Dai C, Stolz DB, Bastacky Si et al. Essential role of integrin-linked kinase in podocytes biology: bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol 2006; 17 (8): 2164-2175
(check this in PDF content)
44
Dessapt CBM, Hayward A, Viberti G, Gnudi L. TGF-p1 and mechanical stretch reduce murine podocytes adhesion to extracellular matrix substrate and modulate p1 integrin expression/ maturation in vitro. Diabetologia 2005; [suppl 1]: A28 (abstract)
(check this in PDF content)
45
Kanasaki K, Kanda Y, Palmsten K et al. Integrin beta1- mediated matrix assembly and signaling are critical for the normal development and function of kidney glomerulus. Dev Biol 2008; 313 (2): 584-593
(check this in PDF content)
46
Riser BL, Ladson-Wofford S, Sharba A et al. TGF-beta receptor expression and binding in rat mesangial cells: modulation by glucose and cyclic mechanical strain. Kidney Int 1999; 56 (2): 428-439
(check this in PDF content)
47
Gruden G, Zonca S, Hayward A et al. Mechanical stretch- induced fibronectin and transforming growth factor-beta 1 production in human mesangial cells is p38 mitogen-activated protein kinase dependent. Diabetes 2000; 49 (4): 655-661
(check this in PDF content)
48
Harris RC, Haralson MA, Badr KF. Continuous stretch- relaxation in culture alters rat mesangial cell morphology, growth characteristics and metabolic activity. Lab Invest 1992; 66 (3): 548-554
(check this in PDF content)
49
Riser BL, Cortes P, Zhao X et al. Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992; 90 (5): 1932-1943
(check this in PDF content)
50
Yasuda T, Kondo S, Homma T, Harris RC. Regulation of extracellular matrix by mechanical stress in rat glomerular mesangial cells. J Clin Invest 1996; 98 (9): 1991-2000
(check this in PDF content)
51
Heilig CW, Concepcion LA, Riser BL et al. Overexpression of glucose transporters in rat mesangial cells cultured in normal glucose milieu mimics diabetic phenotype. J Clin Invest 1995; 96 (8): 1802-1814
(check this in PDF content)
52
Chen S, Heilig KO, Brosius FC, Heilig CW. Diabetes increases glomerular GLUT1 and antisense-GLUT1 protects against diabetic glomerulosclerosis (Abstract). J Am Soc Nephrol 2003; 14: 46A
(check this in PDF content)
53
Gnudi L, Viberti G, Raij L et al. GLUT-1 overexpression: link between hemodynamic and metabolic factors in glomerular injury? Hypertension 2003; 42 (1): 19-24
(check this in PDF content)
54
Gnudi L, Viberti G. The link between mechanical stretch and glucose metabolism - a conceptual advance in understanding diabetic (and nondiabetic?) renal disease. Nephrol Dial Transplant 2007; 22 (2): 318-321
(check this in PDF content)
55
Gruden G, Setti G, Hayward A et al. Mechanical stretch induces monocyte chemoattractant activity via an NF-kappa B-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone. J Am Soc Nephrol 2005; 16 (3): 688-696
(check this in PDF content)
56
Riser BL, Varani J, Cortes P et al. Cyclic stretching of mesangial cells up-regulated intercellular adhesion molecule- 1 and leukocyte adherence: a possible new mechanism for glomerulosclerosis. Am J Pathol 2001; 158 (1): 11-17
(check this in PDF content)
57
Giunti S, Pinach S, Arnoldi L et al. The MCP/CCR2 system has direct proinflammatory effects in human mesangial cells. Kidney Int 2006; 69 (5): 856-863
(check this in PDF content)
58
Giunti S, Tesch GH, Pinach S et al. Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells. Diabetologia 2008; 51 (1): 198-207
(check this in PDF content)
59
Park J, Ryu S, Li JJ et al. MCP/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells. Am J Physiol Renal 2008; 295 (3): F749-F757 Поступила в редакцию 18.08.2009 г.
(check this in PDF content)